Barry Berler - Sharps Technology Chief Inventor

STSS Stock  USD 3.47  0.06  1.70%   

Insider

Barry Berler is Chief Inventor of Sharps Technology
Age 70
Phone631-574-4436
Webhttps://sharpstechnology.com

Sharps Technology Management Efficiency

The company has return on total asset (ROA) of (0.5202) % which means that it has lost $0.5202 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0321) %, meaning that it created substantial loss on money invested by shareholders. Sharps Technology's management efficiency ratios could be used to measure how well Sharps Technology manages its routine affairs as well as how well it operates its assets and liabilities.
Sharps Technology currently holds 3.85 M in liabilities with Debt to Equity (D/E) ratio of 0.56, which is about average as compared to similar companies. Sharps Technology has a current ratio of 2.59, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Sharps Technology's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Wang XinMeihua International Medical
35
Tom AdamsRepro Med Systems
N/A
MScEE MBAGlucoTrack
70
BSN MBAInfuSystems Holdings
45
Jeannine SheehanInfuSystems Holdings
48
Erez BenZviGlucoTrack
46
Brian CaseRepro Med Systems
51
Josh BennettRepro Med Systems
N/A
Keith SchaeferAvinger
N/A
Daniel HabheggerPrecision Optics,
54
Esq CPAGlucoTrack
59
Pr DScMicrobot Medical
72
Rachel VakninMicrobot Medical
45
Lianzhang ZhaoMeihua International Medical
56
David StefanskyNexgel Inc
53
John HargravesPrecision Optics,
N/A
Eyal MDMicrobot Medical
59
David BAGlucoTrack
59
Thomas RuizInfuSystems Holdings
66
Keisha HarcumMilestone Scientific
N/A
Richard ForkeyPrecision Optics,
84
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. The company was incorporated in 2017 and is based in Melville, New York. Sharps Technology operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 3 people. Sharps Technology (STSS) is traded on NASDAQ Exchange in USA. It is located in 105 Maxess Road, Melville, NY, United States, 11747 and employs 57 people. Sharps Technology is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Sharps Technology Leadership Team

Elected by the shareholders, the Sharps Technology's board of directors comprises two types of representatives: Sharps Technology inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sharps. The board's role is to monitor Sharps Technology's management team and ensure that shareholders' interests are well served. Sharps Technology's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sharps Technology's outside directors are responsible for providing unbiased perspectives on the board's policies.
Adam Holdsworth, Managing Director
Robert Hayes, CEO Director
Alan Blackman, Chief CoChairman
Steven MD, Chief Officer
Ben Scheu, Senior Sales
Barry Berler, Chief Inventor
Andrew CPA, Chief Officer

Sharps Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sharps Technology a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Sharps Stock Analysis

When running Sharps Technology's price analysis, check to measure Sharps Technology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sharps Technology is operating at the current time. Most of Sharps Technology's value examination focuses on studying past and present price action to predict the probability of Sharps Technology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sharps Technology's price. Additionally, you may evaluate how the addition of Sharps Technology to your portfolios can decrease your overall portfolio volatility.